Hapila's counter-current crystallisation process provides a cost effective procedure for purification of active pharmaceutical ingredients, completed by experience in synthesis and particle design.
Dr. Uwe Müller
High-Tech Gründerfonds invests in Thuringian Technology Venture „HAPILA GmbH“
Start-up from Gera offers high-efficiency processes for purification of Active Pharmaceutical Ingredients The shareholders and staff of HAPILA GmbH, a provider of sophisticated pharmaceutical and chemical development services located in Gera, are delighted to announce that the High-Tech Gründerfonds has invested in…
Otto Schott Straße 9
28. Aug 2008